| Revenue | 31/12/2016 | 31/12/2015 | 31/12/2014 |
| Total revenue | 79,919,000 | 81,741,000 | 92,793,000 |
| Cost of revenue | 41,625,000 | 41,057,000 | 46,386,000 |
| Gross profit | 38,294,000 | 40,684,000 | 46,407,000 |
| Operating expenses |
| Research development | 5,751,000 | 5,247,000 | 5,437,000 |
| Selling general and administrative | 19,438,000 | 19,748,000 | 22,438,000 |
| Non-recurring | - | - | - |
| Others | - | - | - |
| Total operating expenses | - | - | - |
| Operating income or loss | 13,105,000 | 15,689,000 | 18,532,000 |
| Income from continuing operations |
| Total other income/expenses net | -145,000 | 724,000 | 1,938,000 |
| Earnings before interest and taxes | 12,960,000 | 16,413,000 | 20,470,000 |
| Interest expense | 630,000 | 468,000 | 484,000 |
| Income before tax | 12,330,000 | 15,945,000 | 19,986,000 |
| Income tax expense | 449,000 | 2,581,000 | 4,234,000 |
| Minority interest | 146,000 | 162,000 | 146,000 |
| Net income from continuing ops | 11,881,000 | 13,364,000 | 15,751,000 |
| Non-recurring events |
| Discontinued operations | -9,000 | -174,000 | -3,729,000 |
| Extraordinary items | - | - | - |
| Effect of accounting changes | - | - | - |
| Other items | - | - | - |
| Net income |
| Net income | 11,872,000 | 13,190,000 | 12,022,000 |
| Preferred stock and other adjustments | - | - | - |
| Net income applicable to common shares | 11,872,000 | 13,190,000 | 12,022,000 |
